Full Text
EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis

Abstract

Authors

NW Leong Y Yang

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×